Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

4.25
Delayed Data
As of Feb 17
 +0.15 / +3.66%
Today’s Change
2.63
Today|||52-Week Range
6.30
+17.40%
Year-to-Date
ImmunoGen Posts Wider-than-Expected Loss; Sales Down Y/Y
Feb 20 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb 16 / Zacks.com - Paid Partner Content
Mylan's Proposed Biosimailar for Cancer Under Review in U.S.
Feb 17 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Q4 Loss Narrower than Expectations, Sales Beat
Feb 16 / Zacks.com - Paid Partner Content
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb 17 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y
Feb 16 / Zacks.com - Paid Partner Content
Agios Pharma (AGIO) Q4 Loss Narrower than Expected; Stock Up
Feb 17 / Zacks.com - Paid Partner Content
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4
Feb 15 / Zacks.com - Paid Partner Content
Boxer Capital, LLC Buys AveXis, BeiGene, Alnylam Pharmaceuticals, Sells Biomarin ...
Feb 16 / GuruFocus News - Paid Partner Content
AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates
Feb 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.10
Today’s open4.10
Day’s range4.10 - 4.31
Volume89,590
Average volume (3 months)60,248
Market cap$88.7M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+34.21%
Earnings growth (this year)+18.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-46.62%
P/E ratioNM
Price/Sales21.38
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV0.000.00%
NOVNNovan Inc-0.27-4.57%
SCYXSCYNEXIS Inc+0.13+3.72%
SBBPStrongbridge Biophar...+0.15+6.12%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$3.1M
Annual profit (last year)-$36.7M
Net profit margin-1,198.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs